NEA Management Company, LLC - Q1 2022 holdings

$3.46 Billion is the total value of NEA Management Company, LLC's 57 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 28.6% .

 Value Shares↓ Weighting
BuyIONQ INC$373,585,000
-23.5%
29,277,852
+0.2%
10.79%
+9.4%
NewARCELLX INC$72,206,0006,437,764
+100.0%
2.09%
AUPH BuyAURINIA PHARMACEUTICALS INC$49,146,000
-30.0%
3,969,834
+29.3%
1.42%
+0.1%
BuyMINERVA SURGICAL INC$40,508,000
-21.2%
10,001,937
+0.0%
1.17%
+12.6%
GERN BuyGERON CORP$22,193,000
+35.1%
16,318,681
+21.2%
0.64%
+93.1%
BILL BuyBILL COM HLDGS INC$14,241,000
-13.5%
66,100
+0.0%
0.41%
+23.4%
GLBE NewGLOBAL E ONLINE LTD$13,264,000436,282
+100.0%
0.38%
RGLS BuyREGULUS THERAPEUTICS INC$4,306,000
+108.6%
14,451,147
+124.0%
0.12%
+195.2%
TCON BuyTRACON PHARMACEUTICALS INC$912,000
-5.0%
346,719
+0.0%
0.03%
+36.8%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GLYCOMIMETICS INC39Q3 20237.6%
AURINIA PHARMACEUTICALS INC37Q3 20235.0%
CHAMPIONS ONCOLOGY INC33Q3 20231.2%
LEXICON PHARMACEUTICALS INC32Q3 20232.0%
ADAPTIMMUNE THERAPEUTICS PLC31Q3 20239.3%
TREVENA INC31Q3 20213.3%
AKARI THERAPEUTICS PLC31Q2 20230.3%
ARDELYX INC29Q3 202111.9%
RIGEL PHARMACEUTICALS INC29Q2 20200.6%
EPIZYME INC28Q1 20209.6%

View NEA Management Company, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-10
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-12

View NEA Management Company, LLC's complete filings history.

Compare quarters

Export NEA Management Company, LLC's holdings